Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Side Effects of Atropine (SEA) Study

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Nuoroda įrašoma į mainų sritį
StatusasBaigta
Rėmėjai
Jeffrey J. Walline, OD PhD

Raktažodžiai

Santrauka

This study will perform several objective and subjective measurements of the eye and vision before and after a week of using 0.01% concentration atropine drops. These measurements will help to obtain a comprehensive understanding of the side effects of this concentration of atropine and determine if the drops would be tolerated as a possible preventative treatment for nearsightedness.

apibūdinimas

Atropine drops are commonly used to dilate the eye and prevent the ability to focus and also slow the progression of nearsightedness. Low concentration (0.01%) atropine slows the progression of myopia 60% to 83% while causing less side effects than high concentration (1.0%) atropine though still showing an effect on pupil size and pupil response.This study is a prospective cohort study in which several objective and subjective measurements will be taken before and after the use of 0.01% atropine for a week to determine the effect of this concentration on 1. vision at distance and near; 2. pupil size; 3. focusing ability, accuracy, and change; 4. symptoms, including subjective vision, headaches, light sensitivity, drop comfort; and 5. pressure in the eye. This will allow us to determine the effect these drops have on the eye and whether or not patients would be willing to use them as a possible preventative treatment for nearsightedness. The investigators expect to find that the drops will not affect vision, will increase pupil size, decrease focusing ability and accuracy (but not clinically meaningfully), cause some light sensitivity, and have no effect on eye pressure. The investigators expect that patients would be willing to use these drops to control nearsightedness even after experiencing the side effects.

Datos

Paskutinį kartą patikrinta: 02/29/2020
Pirmasis pateikimas: 06/26/2018
Numatytas registravimas pateiktas: 07/17/2018
Pirmas paskelbtas: 07/18/2018
Paskutinis atnaujinimas pateiktas: 03/01/2020
Paskutinis atnaujinimas paskelbtas: 03/03/2020
Faktinė studijų pradžios data: 07/22/2018
Numatoma pirminio užbaigimo data: 01/16/2019
Numatoma studijų užbaigimo data: 01/16/2019

Būklė ar liga

Myopia

Intervencija / gydymas

Drug: One Week Atropine

Fazė

Fazė 1/Fazė 2

Rankų grupės

RankaIntervencija / gydymas
Experimental: One Week Atropine
0.01% concentration atropine drops
Drug: One Week Atropine
One drop of 0.01% concentration atropine in each eye at night for seven days.

Tinkamumo kriterijai

Amžius, tinkami studijuoti 21 Years Į 21 Years
Tinkamos studijoms lytysAll
Priima sveikus savanoriusTaip
Kriterijai

Inclusion Criteria:

-N/A

Exclusion Criteria:

- Outside of age range

- History of accommodative (focusing) issues or therapy

Rezultatas

Pirminės rezultatų priemonės

1. Diameter of the pupil measured with a Neuroptix Pupillometer [One week after beginning treatment with drops]

Change in pupil size from before treatment to after one week on treatment in millimeters to the nearest tenth of a millimeter

2. Visual Acuity with Bailey-Lovie logMAR visual acuity charts [One week after beginning treatment with drops]

Investigators will measure the change in high contrast distance and near logMAR visual acuity and low contrast distance logMAR visual acuity.

Antrinės rezultatų priemonės

1. Eye focusing measured by the closest one can read a letter, focusing accuracy measured by an autorefractor, and ability to change focus from far to near measured by stimulating and relaxing focus of the eyes as many times as possible in one minute. [One week after beginning treatment with drops]

Investigators will measure near point of accommodation (how close an object can be seen clearly) in centimeters, accommodative lag (error of focusing on near objects) in diopters, and accommodative facility (ability to change focus from far to near) in number of cycles

2. Change in subjective assessment of potential side effects by asking the same questions before and after administration of eye drops. [One week after beginning treatment with drops]

Investigators will ask survey questions about drop comfort, likelihood of taking the drop long-term, vision, light sensitivity, glare, ghosting, and headaches.

3. Change in Intraocular Pressure using a Tonopen [One week after beginning treatment with drops]

We will measure the eye pressure before using drops and after one week of using drops to see if the pressure changes

Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge